Format

Send to

Choose Destination
J Infus Nurs. 2006 Jul-Aug;29(4):225-31.

Summary of product trials for 10, 164 patients: comparing an intravenous stabilizing device to tape.

Author information

1
Mayo Clinic, Rochester, Minnesota 55905, USA. Schears.gregory@mayo.edu

Erratum in

  • J Infus Nurs. 2006 Sep-Oct;29(5):242.

Abstract

Inadequate catheter securement is an underrecognized patient safety issue that contributes significantly to catheter-related complications, including dislodgment, occlusion, infiltration, and infection. Pooled data from prospective product trials at 83 hospitals compared tape to a standard peripheral intravenous (PIV) securement method with a PIV-specific catheter-stabilizing device (StatLock). A 67% reduction (P<.001) in total patient complications was observed in the stabilizing device group, as compared with the tape group. Also, the need for unscheduled PIV restarts was reduced by 76% with the stabilizing device (P<.001). An annual cost savings of $18,000 per hospital on PIV materials and a combined savings of $277,000 on materials, complication costs, and nursing time were estimated on the basis of these reduced complications. Newer catheter-stabilizing technologies can help to reduce patient complications, for an overall cost savings, and consequently reduce needlestick exposures for healthcare providers by reducing restarts and prolonging dwell times.

PMID:
16858255
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center